Thymosin Α1 Market

What is Thymosin α1?
Thymosin α1 is a protein in humans encoded by the PTMA gene, which is a peptide fragment derived from prothymosin alpha, exhibits a variety of immunoregulating properties. It is approved for the treatment of Hepatitis B and C, in 35 under-developed or developing countries.

Global Thymosin α1 Market Outlook
The rising burden and incidence of HAV and HBV are driving the growth of Thymosin α1 market. In 2015, 257 million people were diagnosed with chronic HBV infection, and 71 million people with chronic HCV infection, this figure to reach a peak by 2030. Eastern Mediterranean Region and the European Region are reported with the highest prevalence of HCV.
Ongoing trials and research for new applications or treatments to propel the growth of the market. Clinical trials entail that thymosin α1 can be useful in cystic fibrosis, peritonitis, acute cytomegalovirus infection, TB, severe acute respiratory syndrome, and lung infections in critically ill patients., septic shock and acute respiratory distress syndrome. It has been studied for probable use in treating cancer during chemotherapy. Thymosin α1 has been given to subjects with lung, gastric, or breast cancer in China. It was given for evaluation during one of two cycles of chemotherapy and QOL, treatment with Thymosin α1 provided a significant improvement in all measures of QOL as well as a lowered occurrence of infections during chemotherapy and increased immune parameters. Lack of awareness among the rural population about hepatitis and its treatment is hindering the growth of the market.

Global Thymosin α1 Market Competitive Landscape
The "Global Thymosin α1 Market" study report will provide a valuable insight with an emphasis on global market including some of the major players such as Suzhou Tianma Pharma Group Tianji Bio-pharmaceutical, Hainan Zhonghe Pharmaceutical, SciClone Pharmaceuticals, Abbiotec, Shanghai Soho-Yiming Pharmaceuticals, Hybio Pharmaceutical and Hainan Shuangcheng Pharmaceuticals. Our market analysis also entails a section solely dedicated for such major players wherein our analysts provide an insight to the financial statements of all the major players, along with its product benchmarking and SWOT analysis.

Customization of the Report
• In case of any queries or customization requirements please connect with our sales team, who will ensure that your requirements are met.

1. INTRODUCTION OF GLOBAL THYMOSIN Α1 MARKET
1.1. Overview of the Market
1.2. Scope of Report
1.3. Assumptions

2. EXECUTIVE SUMMARY

3. RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH
3.1. Data Mining
3.2. Validation
3.3. Primary Interviews
3.4. List of Data Sources

4. GLOBAL THYMOSIN Α1 MARKET OUTLOOK
4.1. Overview
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.3. Porters Five Force Model
4.4. Value Chain Analysis
5. GLOBAL THYMOSIN Α1 MARKET, BY TYPE
5.1. Overview
5.2. Freeze-dried Powder
5.3. Injection

6. GLOBAL THYMOSIN Α1 MARKET, BY DISTRIBUTION CHANNEL
6.1. Overview
6.2. Hospital Pharmacies
6.3. Retail Pharmacies
6.4. Online Pharmacies

7. GLOBAL THYMOSIN Α1 MARKET, BY GEOGRAPHY
7.1. Overview
7.2. North America
7.2.1. U.S.
7.2.2. Canada
7.2.3. Mexico
7.3. Europe
7.3.1. Germany
7.3.2. U.K.
7.3.3. France
7.3.4. Rest of Europe
7.4. Asia Pacific
7.4.1. China
7.4.2. Japan
7.4.3. India
7.4.4. Rest of Asia Pacific
7.5. Rest of the World
7.5.1. Latin America
7.5.2. Middle East & Africa

8. GLOBAL THYMOSIN Α1 MARKET COMPETITIVE LANDSCAPE
8.1. Overview
8.2. Company Market Ranking
8.3. Key Development Strategies
9. COMPANY PROFILES
9.1. Suzhou Tianma Pharma Group Tianji Bio-pharmaceutical
10.1.1 Overview
10.1.2 Financial Performance
10.1.3 Product Outlook
10.1.4 Key Developments
9.2. Abbiotec
9.2.1. Overview
9.2.2. Financial Performance
9.2.3. Product Outlook
9.2.4. Key Developments
9.3. Shanghai Soho-Yiming Pharmaceuticals
9.3.1. Overview
9.3.2. Financial Performance
9.3.3. Product Outlook
9.3.4. Key Developments
9.4. Hybio Pharmaceutical
9.4.1. Overview
9.4.2. Financial Performance
9.4.3. Product Outlook
9.4.4. Key Developments
9.5. Hainan Shuangcheng Pharmaceuticals
9.5.1. Overview
9.5.2. Financial Performance
9.5.3. Product Outlook
9.5.4. Key Developments
10. Appendix
10.1. Related Reports

Global and Chinese Thymosin a1 Industry, 2019 Market Research Report

Published Date : May 2018

The 'Global and Chinese Thymosin a1 Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Thymosin a1 industry with a focus on the Chinese market. The report provides key statistics on the market status of the Thymosin a1 manufacturers an...

Global and Chinese Thymosin Alpha Industry, 2019 Market Research Report

Published Date : May 2018

The 'Global and Chinese Thymosin Alpha Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Thymosin Alpha industry with a focus on the Chinese market. The report provides key statistics on the market status of the Thymosin Alpha manufac...

Global and Chinese Thymosin Alpha-1 Market Outlook 2019-2027

Published Date : May 2017

The Thymosin Alpha-1 Market 2017 Report offers detailed analysis of the Thymosin Alpha-1 market over the last five years, and provides extensive market forecasts by region/country and sub sector. It covers the key technological and market trends in the Thymosin Alpha-1 market. It further lays out an...

Global and Chinese Thymosin Alpha Industry, 2019 Market Research Report

Published Date : Sep 2017

The 'Global and Chinese Thymosin Alpha Industry, 2012-2022 Market Research Report' is a professional and in-depth study on the current state of the global Thymosin Alpha industry with a focus on the Chinese market. The report provides key statistics on the market status of the Thymosin Alpha manufac...

 

Select License :

  • Single User : $3950
  • Multiple User : $4750
  • Corporate User : $6750

Happy To Assist You

Assist you at Worldwide Market Reports

We will be happy to help you find what you need. Please call us or write to us:

Worldwide Market Reports Benefits

Custom Research Solution

Talk to our research consultant to design an exclusive report as per your research needs.

Customer Fulfilment

We aim to fulfil client's research demands with tailored research solutions.

Quick Turnaround Time Reports

We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

360-degree Approach

We cover each industry from supply and demand side with an aim to provide a most holistic research study.